Cubist Systematic Strategies LLC lowered its position in Express Scripts Holding Company (NASDAQ:ESRX) by 54.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 24,434 shares of the company’s stock after selling 29,161 shares during the period. Cubist Systematic Strategies LLC’s holdings in Express Scripts were worth $1,547,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently modified their holdings of ESRX. Dodge & Cox lifted its position in shares of Express Scripts by 25.7% in the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after purchasing an additional 7,388,021 shares during the period. Pzena Investment Management LLC acquired a new position in shares of Express Scripts in the 2nd quarter worth approximately $181,234,000. Northern Trust Corp lifted its position in shares of Express Scripts by 12.2% in the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after purchasing an additional 1,206,980 shares during the period. Ameriprise Financial Inc. increased its stake in shares of Express Scripts by 23.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after acquiring an additional 996,816 shares in the last quarter. Finally, Veritas Asset Management LLP increased its stake in shares of Express Scripts by 13.2% in the 2nd quarter. Veritas Asset Management LLP now owns 8,192,572 shares of the company’s stock valued at $523,014,000 after acquiring an additional 952,249 shares in the last quarter. Hedge funds and other institutional investors own 88.44% of the company’s stock.
In other news, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total value of $40,103.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Timothy C. Wentworth bought 8,000 shares of Express Scripts stock in a transaction dated Tuesday, October 31st. The stock was purchased at an average price of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. Corporate insiders own 0.68% of the company’s stock.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.90. The business had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. Express Scripts’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.74 EPS. equities research analysts forecast that Express Scripts Holding Company will post 7.02 earnings per share for the current fiscal year.
Several research firms have recently weighed in on ESRX. Jefferies Group set a $80.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a research note on Friday. Royal Bank of Canada set a $68.00 price objective on shares of Express Scripts and gave the company a “hold” rating in a research note on Friday. Raymond James Financial reiterated a “sell” rating on shares of Express Scripts in a research note on Friday. Robert W. Baird upgraded shares of Express Scripts from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $72.00 to $81.00 in a research note on Friday. Finally, SunTrust Banks set a $82.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a research note on Thursday. Five research analysts have rated the stock with a sell rating, ten have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Express Scripts has a consensus rating of “Hold” and a consensus price target of $74.40.
ILLEGAL ACTIVITY NOTICE: “Express Scripts Holding Company (ESRX) Stake Lessened by Cubist Systematic Strategies LLC” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://sportsperspectives.com/2017/12/17/express-scripts-holding-company-esrx-stake-lessened-by-cubist-systematic-strategies-llc.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.